SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer
SU086 是一种 HSP90 抑制剂，可抑制糖酵解，是晚期前列腺癌的一种治疗策略。
期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2021.100502
Meghan A Rice ,Vineet Kumar ,Dhanir Tailor ,Fernando Jose Garcia-Marques ,En-Chi Hsu ,Shiqin Liu ,Abel Bermudez ,Vijayalakshmi Kanchustambham ,Vishnu Shankar ,Zintis Inde ,Busola Ruth Alabi ,Arvind Muruganantham ,Michelle Shen ,Mallesh Pandrala ,Rosalie Nolley ,Merve Aslan ,Ali Ghoochani ,Arushi Agarwal ,Mark Buckup ,Manoj Kumar ,Catherine C Going ,Donna M Peehl ,Scott J Dixon ,Richard N Zare ,James D Brooks ,Sharon J Pitteri ,Sanjay V Malhotra ,Tanya Stoyanova
